For the first time, we demonstrate that increasing anti-oxLDL IgM autoantibodies ameliorates motor function decay, neuro- and hepatic inflammation as well as hepatic cholesterol metabolism in NPC1 disease. The gene discussed is CD40LG; the disease is Niemann-Pick disease, type C1.